Researchers from the National Institutes of Natural Sciences and Nagoya City University have achieved a significant breakthrough by elucidating the structure of amyloid β (Aβ) bound to glycolipids on the surface of nerve cells. This finding shed light on the critical role of abnormal Aβ fibril formation, a major contributor to Alzheimer’s disease, and holds promise for innovative advancements in medicine and pharmacy.